The Operating Framework for the NHS in England 2011/12

This document offers a précis of the publication of the NHS operating framework which takes into account the proposed government changes to the structure of the NHS. The operating framework sets out what needs to happen in the NHS over the coming year 2011-12. Given the reforms set out in the Government’s white papers and the efficiency savings envisaged under the Spending Review settlement, as well as the drive to improve quality under the QIPP programme, this will be a year of significant transition for the NHS.

The document states the intention to ‘maintain a strong grip on the system during 2011-12’ and in practice this will involve Strategic health authorities (SHAs) playing a key role until their abolition in April 2012. They will oversee the clustering of PCTs with joint management boards so that the dual challenge of meeting efficiency savings and supporting newly emerging GP led commissioning consortia is met.

The operating framework refers to reductions in the ‘overall running costs of the new NHS superstructure’ which will decrease by one third by 2014/15. This relates to £1.7b worth of running costs.

In addition, the framework:

  • Gives an initial indication of the management allowance for GP consortia running costs in the range of £25 to £35 per head of population by 2014/15. The final figure will not be determined until further work has been undertaken with the GP consortia pathfinders.
  • Maintains tight financial control of the NHS throughout 2011.12 by PCTs holding back 2% of their allocation to create ‘financial flexibility and headroom to support change’
  • Extends the time frame to meet the challenge of £20 billion to the end of 2014/15. The NHS had been working towards meeting efficiency savings of £15-20 billion over the next three years. But the operating framework says that an improved level of funding compared to the scenario in 2009; the adoption of a pay freeze for most NHS staff for two years; and deeper than originally thought reductions in management and administration costs has enabled the time period to be extended.
  • Reduces the overall tariff between 2010/11 and 2011/12 by 1.5%. This reduction is achieved through changing the way in which long stays in hospital are funded; reducing all tariffs by 1% as an initial step in policy to set tariffs below the national average level; and off-setting pay and prices uplifts of 2%. The NHS tariff will become a maximum rather than a set price for treatments from April 2011. This signals the introduction of price competition among NHS providers.
  • States that PCTs will be given responsibility for securing post-discharge support, with hospitals responsible for any readmissions within 30 days of discharge.
  • States that all NHS trusts will become NHS foundation trusts by the end of 2013/14 and that it will not be an option for organisations to decide to remain as an NHS trust.

The Operating Framework for 2011/12 does mention pharmacy and states that:

It is important that NHS organisations continue to maintain and develop pharmaceutical services, including local enhanced services to meet pharmaceutical needs. Optimising the use of medicines in people with newly diagnosed long term conditions, and targeting of Medicines Use Reviews are areas that SHAs and PCTs should actively engage in. In addition, evidence continues to build for the provision of public health services through community pharmacies, as highlighted in Healthy Lives, Healthy People: Our strategy for public health in England.

Commissioning transition timetable

Now – March 2011 PCTs to involve GP practices and emerging consortia, with other clinicians, in the 2011/12 contracting round and the broader commissioning cycle from 2011/12 onwards
December 2010 Initial GP consortia pathfinders identified
January – March 2011 Delegated responsibilities of pathfinder consortia confirmed with PCTs
January 2011 – March 2012 Further pathfinders identified and emerging consortia encouraged to become increasingly involved in commissioning and take on increasing delegated responsibilities
In 2011/12 NHS Commissioning Board set up in shadow form as special health authority
June 2011 PCT clustering arrangements in place
April 2012 All GP practices in GP consortia and start of NHS Commissioning Board authorisation of consortia
April 2012 NHS Commissioning Board established, takes over relevant responsibilities
April 2012 SHAs abolished and responsibilities allocated to bodies in the 2012/13 architecture
April 2012 – March 2013 NHS Commissioning Board to work with GP consortia that need further support to be ready to take on full statutory responsibilities
April 2013 Authorised GP consortia take on full statutory responsibilities
April 2013 PCTs abolished

Points for pharmacy:

  • The new revised Operating Framework for NHS will result in hard hitting cost reduction targets within the managed sector. Pharmacists employed by the NHS can bring enormous value. This includes managing the drugs budget nationally, regionally and locally, improving the discharge processes, ensuring safe practice in relation to medicines, effective medicine management and reducing the number of prescribing incidents.
  • The patient facing and strategic roles that pharmacists have within the NHS are essential to delivering a safe, clinically effective service that delivers value for the taxpayer and improves clinical outcomes for patients.
  • Pharmacists in communities are the most accessible healthcare professionals, seeing the greatest number of patients on a daily basis. Commissioners need to exploit these opportunities enabling pharmacists to be an integral part of the multidisciplinary health team to improve the delivery of health care and support public health.


Back to Equity and excellence: Liberating the NHS main page »